APIC 2022: Day 2 Report

Preventing Infection

APIC 2022: Day 2 Report

“What the urologist cares about is that the scope is there when the patient is there,” Dr. Adam Lorentz said.

Now is an ideal time for urology departments and infection prevention teams to work more closely together on everything from risk points for potential infections to what types of endoscopes to purchase.

After all, urology is a high-volume specialty with high-risk surgeries performed using complex medical instruments. And yet it typically hasn’t been subject to the same level of infection surveillance scrutiny as other specialties and procedures.

That was one takeaway from a session on Day 2 of the Association for Professionals in Infection Control and Epidemiology (APIC ) annual conference, held in Indianapolis June 13-15. About 1,300 attendees trekked to the Hoosier State’s capital city for the in-person conference while another 1,800 were opting to take in the sessions and continuing education courses online, according to APIC officials.

The session on integrating urology into infection prevention programs was led by Jill Holdsworth, infection prevention manager for Emory University Hospital Midtown in Atlanta, and Dr. Adam Lorentz, a urologist at Emory University Hospital Midtown. Lorentz walked attendees through the diverse range of procedures urologists perform – and the many chances for infection.

He also poked fun at himself and his fellow urologists for wanting a cystoscope processed in 10 minutes or having their eyes glaze over at a ureteroscope manufacturer’s densely worded instructions for use. Clinicians are primarily focused on optimizing quality and efficiency.

“What the urologist cares about is that the scope is there when the patient is there,” Lorentz said.

Recent regulatory scrutiny makes the timing right for this kind of enhanced collaboration with IPs. In April 2021, the U.S. Food and Drug Administration said it was investigating “numerous” medical device reports (MDRs) describing patient infections and other possible contamination issues possibly associated with reprocessed urological endoscopes.

These endoscopes include cystoscopes, ureteroscopes, and cystourethroscopes.

Between Jan. 1, 2017, and Feb. 20, 2021, the FDA received more than 450 MDRs describing post-procedure patient infections or other potential contamination issues involving reprocessing these endoscopes.

Some reports have indicated issues with inadequate reprocessing or maintenance. Other potential issues the FDA is evaluating include device design and reprocessing instructions on labeling.

Earlier this year, a comprehensive review and analysis of adverse event reports involving flexible endoscopes filed with the U.S. Food and Drug Administration showed a marked increase for six types of scopes from 2014 through 2021. These include urological endoscopes.

Medical device manufacturers such as Boston Scientific Corp. and Ambu A/S have developed single-use endoscopes, including cystoscopes, touting their availability and ability to eliminate patient cross-contamination because they are used once and discarded. Lorentz said his practice is considering single-use scopes.

A formative step, Holdsworth said, could be something as simple as working together on what kinds of scopes to purchase – before they’re acquired only to frustrate urologists for being out of service for reprocessing or damage.

That in turn can lead to impactful initiatives such as targeting catheter-associated urinary tract infections, or CAUTI. Approximately 75 percent of UTIs acquired in a hospital are associated with a urinary catheter, and between  15 percent to 25 percent of patients receive urinary catheters during their hospital stay, according to the U.S. Centers for Disease Control and Prevention

Day 1 of APIC’s annual conference explored the implications of the recently released and highly anticipated update to standards for reprocessing flexible endoscopes, as well as moving medical instrument sterilization offsite and the impact of COVID-19 on the field.

Founded in 1972, APIC counts more than 15,000 members advancing the science and practice of infection prevention and control through research, advocacy, and patient safety; education, credentialing, and certification; and fostering development of the infection prevention and control workforce of the future.

More Infection Prevention Articles
Why Bedside Cleaning is the Most Important Step in Endoscope Reprocessing
Prevention Challenges
“It’s baffling, it’s intriguing, and it is the most important step in the endoscope reprocessing chain,” according to an expert featured on a recent episode of the Beyond Clean podcast.
6 Ways Healthcare Teams Recognize Patient Safety Awareness Week
Patient Safety Awareness Week
Patient Safety Awareness Week, from March 13-19, gives hospitals around the world the perfect opportunity to highlight the many reasons to focus on patient safety.
More From Single-Use Endoscopy
The hope is that awareness of the dysphagia problem will inspire new research and help connect people to resources for help.

Public Health

Swallowing is something that many people take for granted — yet for those who experience difficulty doing it, the challenges can drastically alter their quality of life.

No Outbreak, No Problem? Duodenoscopes May Still Harbor Contamination

Preventing Infection

A recent study found more than 5 percent of reprocessed duodenoscopes harbor “high-concern” organisms despite the lack of an infection outbreak.

Diagnostic bronchoscopy is effective as a tool for patients with COPD

Performing Procedures

Because COPD is a major risk factor for lung cancer and infection and often coexists with other diseases, there was concern that patients could have serious complications when bronchoscopy was performed.